These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29344092)

  • 1. Engaging the primary care community to encourage appropriate prostate cancer screening.
    Patel MP; Schulman A; Shah KP; Anderson JB; Polascik TJ
    Ther Adv Urol; 2018 Jan; 10(1):11-16. PubMed ID: 29344092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary care perspective and implementation of a multidisciplinary, institutional prostate cancer screening algorithm embedded in the electronic health record.
    Aminsharifi A; Schulman A; Anderson J; Fish L; Oeffinger K; Shah K; Sze C; Tay KJ; Tsivian E; Polascik TJ
    Urol Oncol; 2018 Nov; 36(11):502.e1-502.e6. PubMed ID: 30170982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized trial of community health worker-led decision coaching to promote shared decision-making for prostate cancer screening among Black male patients and their providers.
    Makarov DV; Feuer Z; Ciprut S; Lopez NM; Fagerlin A; Shedlin M; Gold HT; Li H; Lynch G; Warren R; Ubel P; Ravenell JE
    Trials; 2021 Feb; 22(1):128. PubMed ID: 33568208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer screening practices in a large, integrated health system: 2007-2014.
    Misra-Hebert AD; Hu B; Klein EA; Stephenson A; Taksler GB; Kattan MW; Rothberg MB
    BJU Int; 2017 Aug; 120(2):257-264. PubMed ID: 28139034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deliberative democracy and cancer screening consent: a randomised control trial of the effect of a community jury on men's knowledge about and intentions to participate in PSA screening.
    Thomas R; Glasziou P; Rychetnik L; Mackenzie G; Gardiner R; Doust J
    BMJ Open; 2014 Dec; 4(12):e005691. PubMed ID: 25539779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinician interest in clinical decision support for PSA-based prostate cancer screening.
    Harper J; Hunt T; Choudry M; Kapron AL; Cooney KA; Martin C; Ambrose J; O'Neil B
    Urol Oncol; 2023 Mar; 41(3):145.e17-145.e23. PubMed ID: 36610816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Provider Perceptions of an Electronic Health Record Prostate Cancer Screening Tool.
    Carlsson SV; Preston M; Vickers A; Malhotra D; Ehdaie B; Healey M; Kibel AS
    Appl Clin Inform; 2024 Mar; 15(2):282-294. PubMed ID: 38599619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Social ecological predictors of prostate-specific antigen blood test and digital rectal examination in black American men.
    Woods VD; Montgomery SB; Herring RP; Gardner RW; Stokols D
    J Natl Med Assoc; 2006 Apr; 98(4):492-504. PubMed ID: 16623061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial Longitudinal Outcomes of Risk-Stratified Men in Their Forties Screened for Prostate Cancer Following Implementation of a Baseline Prostate-Specific Antigen.
    Michael ZD; Kotamarti S; Arcot R; Morris K; Shah A; Anderson J; Armstrong AJ; Gupta RT; Patierno S; Barrett NJ; George DJ; Preminger GM; Moul JW; Oeffinger KC; Shah K; Polascik TJ;
    World J Mens Health; 2023 Jul; 41(3):631-639. PubMed ID: 36047079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Durable improvements in prostate cancer screening from online spaced education a randomized controlled trial.
    Kerfoot BP; Lawler EV; Sokolovskaya G; Gagnon D; Conlin PR
    Am J Prev Med; 2010 Nov; 39(5):472-8. PubMed ID: 20965387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formative evaluation of the prostate cancer screening practices of African-American physicians.
    Stroud L; Ross LE; Rose SW
    J Natl Med Assoc; 2006 Oct; 98(10):1637-43. PubMed ID: 17052055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decision fatigue in low-value prostate cancer screening.
    Hunt TC; Ambrose JP; Haaland B; Kawamoto K; Dechet CB; Lowrance WT; Hanson HA; O'Neil BB
    Cancer; 2021 Sep; 127(18):3343-3353. PubMed ID: 34043813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing use of the prostate-specific antigen screening test in primary care.
    Moran WP; Cohen SJ; Preisser JS; Wofford JL; Shelton BJ; McClatchey MW
    Am J Manag Care; 2000 Mar; 6(3):315-24. PubMed ID: 10977432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality: The CAP Randomized Clinical Trial.
    Martin RM; Donovan JL; Turner EL; Metcalfe C; Young GJ; Walsh EI; Lane JA; Noble S; Oliver SE; Evans S; Sterne JAC; Holding P; Ben-Shlomo Y; Brindle P; Williams NJ; Hill EM; Ng SY; Toole J; Tazewell MK; Hughes LJ; Davies CF; Thorn JC; Down E; Davey Smith G; Neal DE; Hamdy FC;
    JAMA; 2018 Mar; 319(9):883-895. PubMed ID: 29509864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minority issues in prostate disease.
    French DB; Jones LA
    Med Clin North Am; 2005 Jul; 89(4):805-16. PubMed ID: 15925651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation and Impact of a Risk-Stratified Prostate Cancer Screening Algorithm as a Clinical Decision Support Tool in a Primary Care Network.
    Shah A; Polascik TJ; George DJ; Anderson J; Hyslop T; Ellis AM; Armstrong AJ; Ferrandino M; Preminger GM; Gupta RT; Lee WR; Barrett NJ; Ragsdale J; Mills C; Check DK; Aminsharifi A; Schulman A; Sze C; Tsivian E; Tay KJ; Patierno S; Oeffinger KC; Shah K
    J Gen Intern Med; 2021 Jan; 36(1):92-99. PubMed ID: 32875501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate specific antigen screening for prostate cancer: knowledge of, attitudes towards, and utilization among primary care physicians.
    Tasian GE; Cooperberg MR; Cowan JE; Keyashian K; Greene KL; Daniels NA; Carroll PR; Chan JM
    Urol Oncol; 2012; 30(2):155-60. PubMed ID: 20800514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What should men know about prostate-specific antigen screening before giving informed consent?
    Chan EC; Sulmasy DP
    Am J Med; 1998 Oct; 105(4):266-74. PubMed ID: 9809686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors Related to Prostate-Specific Antigen-Based Prostate Cancer Screening in Primary Care: Retrospective Cohort Study of 120,587 French Men Over the Age of 50 Years.
    Rat C; Schmeltz H; Rocher S; Nanin F; Gaultier A; Nguyen JM
    JMIR Public Health Surveill; 2018 Oct; 4(4):e10352. PubMed ID: 30355559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive properties of serum-prostate-specific antigen testing in a community-based setting.
    Jacobsen SJ; Bergstralh EJ; Guess HA; Katusic SK; Klee GG; Oesterling JE; Lieber MM
    Arch Intern Med; 1996 Nov; 156(21):2462-8. PubMed ID: 8944739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.